HIGHLIGHTS
- who: Gianfranco Lapietra et al. from the Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy have published the research: Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment, in the Journal: Biomolecules 2022, 12, 1146. of /2022/
- what: The study showed satisfactory ORR, with the most benefit coming from the addition of steroids. The study showed statistically significant differences regarding ORR and PFS in favour of the experimental arm, with a benefit being consistent across all the subgroups, including those with high-risk cytogenetics , even . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.